First Time Loading...

Augmedix Inc
NASDAQ:AUGX

Watchlist Manager
Augmedix Inc Logo
Augmedix Inc
NASDAQ:AUGX
Watchlist
Price: 4.09 USD 1.24% Market Closed
Updated: Mar 29, 2024

Intrinsic Value

AUGX's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. [ Read More ]

The intrinsic value of one AUGX stock under the Base Case scenario is 6.37 USD. Compared to the current market price of 4.09 USD, Augmedix Inc is Undervalued by 36%.

Key Points:
AUGX Intrinsic Value
Base Case
6.37 USD
Undervaluation 36%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Augmedix Inc

Backtest AUGX Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling AUGX stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of Augmedix Inc's business.

What risks and challenges
does Augmedix Inc face in the near future?

Summarize the latest earnings report
of Augmedix Inc.

Provide P/E
for Augmedix Inc and its competitors.

Financials

Balance Sheet Decomposition
Augmedix Inc

Current Assets 33.1m
Cash & Short-Term Investments 21.6m
Receivables 9.5m
Other Current Assets 2m
Non-Current Assets 7.8m
PP&E 6.3m
Other Non-Current Assets 1.5m
Current Liabilities 24.7m
Accounts Payable 1.8m
Accrued Liabilities 6.5m
Other Current Liabilities 16.4m
Non-Current Liabilities 15.4m
Long-Term Debt 12.6m
Other Non-Current Liabilities 2.8m
Efficiency

Earnings Waterfall
Augmedix Inc

Revenue
40.9m USD
Cost of Revenue
-21.6m USD
Gross Profit
19.3m USD
Operating Expenses
-39.2m USD
Operating Income
-19.9m USD
Other Expenses
-420k USD
Net Income
-20.3m USD

Free Cash Flow Analysis
Augmedix Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

AUGX Profitability Score
Profitability Due Diligence

Augmedix Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional 3-Years Revenue Growth
Exceptional Revenue Growth Forecast
Positive Gross Profit
43/100
Profitability
Score

Augmedix Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

AUGX Solvency Score
Solvency Due Diligence

Augmedix Inc's solvency score is 25/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Short-Term Solvency
Long-Term Solvency
High D/E
25/100
Solvency
Score

Augmedix Inc's solvency score is 25/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AUGX Price Targets Summary
Augmedix Inc

Wall Street analysts forecast AUGX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AUGX is 6.92 USD with a low forecast of 5.96 USD and a high forecast of 8.4 USD.

Lowest
Price Target
5.96 USD
46% Upside
Average
Price Target
6.92 USD
69% Upside
Highest
Price Target
8.4 USD
105% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

AUGX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

AUGX Price
Augmedix Inc

1M 1M
-7%
6M 6M
-21%
1Y 1Y
+138%
3Y 3Y
-18%
5Y 5Y
-18%
10Y 10Y
-18%
Annual Price Range
4.09
52w Low
1.65
52w High
5.93
Price Metrics
Average Annual Return -43.53%
Standard Deviation of Annual Returns 11.77%
Max Drawdown -86%
Shares Statistics
Market Capitalization 198.6m USD
Shares Outstanding 48 555 200
Percentage of Shares Shorted 2.62%

AUGX Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Augmedix Inc Logo
Augmedix Inc

Country

United States of America

Industry

Health Care

Market Cap

198.6m USD

Dividend Yield

0%

Description

Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. The company is headquartered in San Francisco, California and currently employs 706 full-time employees. The company went IPO on 2021-03-04. The Company’s Ambient Automation Platform converts the natural conversation between physicians and patients into timely and comprehensive medical notes and provides a suite of related services. The medical note is generated using Augmedix’s proprietary platform, which incorporates structured data models, automatic speech recognition and natural language processing and is overseen by trained medical documentation specialists (MDS). Augmedix provides service from approximately nine MDS operations centers across four countries: the United States, Bangladesh, India and Sri Lanka.

Contact

CALIFORNIA
San Francisco
111 Sutter Street, Suite 1300, Suite Ll
+15619892208.0
https://augmedix.com/

IPO

2021-03-04

Employees

706

Officers

President, CEO, Secretary & Director
Mr. Emmanuel Krakaris
Founder, Chief Strategy Officer & Director
Mr. Ian Shakil
Chief Operating Officer
Ms. Sandra Breber
Chief Technology Officer
Mr. Saurav Chatterjee Ph.D.
Chief Financial Officer
Mr. Paul Louis Ginocchio
Head of Legal & Compliance
Todd Holvick
Show More
Head of People
Lia Wallick
Chief Medical Officer
Dr. Davin Lundquist M.D.
Chief Revenue Officer
Mr. Jonathan Hawkins
Senior Vice President of Engineering
Mr. Tomer Levy
Show Less

See Also

Discover More
What is the Intrinsic Value of one AUGX stock?

The intrinsic value of one AUGX stock under the Base Case scenario is 6.37 USD.

Is AUGX stock undervalued or overvalued?

Compared to the current market price of 4.09 USD, Augmedix Inc is Undervalued by 36%.